Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126423161 | 12642316 | 1 | I | 20160802 | 20160810 | 20160810 | EXP | DE-ASTRAZENECA-2016SE83318 | ASTRAZENECA | 33.00 | YR | M | Y | 0.00000 | 20160810 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126423161 | 12642316 | 1 | PS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | Y | 19810 | ||||||||||
126423161 | 12642316 | 2 | C | LOSARTAN. | LOSARTAN | 1 | 0 | ||||||||||||
126423161 | 12642316 | 3 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | ||||||||||||
126423161 | 12642316 | 4 | C | SILDENAFIL. | SILDENAFIL | 1 | 0 | ||||||||||||
126423161 | 12642316 | 5 | C | TESTOSTERONE PROPIONATE. | TESTOSTERONE PROPIONATE | 1 | Intravenous (not otherwise specified) | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126423161 | 12642316 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126423161 | 12642316 | Fatigue | |
126423161 | 12642316 | Product use issue | |
126423161 | 12642316 | Renal tubular acidosis | |
126423161 | 12642316 | Tubulointerstitial nephritis | |
126423161 | 12642316 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |